NURS6030: Genetics and Genomics in Advanced Nursing Practice –

Module 4: Pharmacogenomics and Precision Medicine in Advanced Practice

As healthcare moves toward personalized treatment, the Advanced Practice Nurse (APN) must understand how genetic variations influence drug metabolism, efficacy, and toxicity. This module focuses on the clinical application of pharmacogenomic data to improve patient safety and therapeutic outcomes.

Assignment 3: Pharmacogenomic Case Analysis and Prescribing Protocol

Overview

This assignment requires you to analyze a clinical case study where a patient’s genetic profile necessitates a modification in standard pharmacological treatment. You will demonstrate the ability to interpret laboratory reports and apply Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines to clinical decision-making.

Instructions and Guidelines

1. Case Selection

   • Select one of the following drug-gene pairs for your analysis:

     • Clopidogrel and CYP2C19 (Cardiology)

     • Warfarin and VKORC1/CYP2C9 (Anticoagulation)

     • Selective Serotonin Reuptake Inhibitors (SSRIs) and CYP2D6 (Psychiatry)

     • Abacavir and HLA-B5701* (Infectious Disease)

2. Genetic Data Interpretation

   • Explain the functional significance of the patient’s genotype (e.g., poor metabolizer, ultra-rapid metabolizer).

   • Describe the pharmacokinetic or pharmacodynamic impact of this specific variant on the chosen medication.

3. Clinical Application

   • Formulate a revised prescribing plan based on the genetic results.

   • Provide a clear rationale for either a dosage adjustment or the selection of an alternative therapeutic agent.

     Writing a Similar Assignment?

     Get a Scholar-Written Paper Matched to Your Brief

     Every order is handled by a degree-holding expert in your subject — written to your exact rubric, fully original, and delivered ahead of your deadline.

     Start My Order

   • Use current CPIC or FDA-approved labeling to support your recommendations.

4. Patient Education and Counseling

   • Outline how you would explain these genetic results to a patient with no scientific background.

   • Address potential concerns regarding the cost-benefit of testing and the implications for family members.

Grading Rubric (Criteria)

Peer-Reviewed References

• Caudle, K. E., et al. (2024). ‘Standardizing Pharmacogenomic Terms and Clinical Implementation: 2024 Update from CPIC’, Clinical Pharmacology & Therapeutics, 115(2), pp. 210-225. https://doi.org/10.1002/cpt.3105

• Johnson, J. A. and Cavallari, L. H. (2023). Pharmacogenetics: A Guide for the Clinician. 2nd edn. New York: McGraw Hill. https://accesspharmacy.mhmedical.com/book.aspx?bookid=3255

• Relling, M. V. and Evans, W. E. (2025). ‘Pharmacogenomics in the Era of Precision Medicine’, New England Journal of Medicine, 392(4), pp. 312-324. https://doi.org/10.1056/NEJMra2400123

• Wheeler, S. (2024). ‘Nursing Responsibilities in Pharmacogenomic Testing and Treatment’, Journal of Personalized Medicine, 14(1), pp. 88. https://doi.org/10.3390/jpm14010088

2. Write a comprehensive ethical inquiry for NUR3306 focusing on Direct-to-Consumer genetic testing. This guide details case study selection, the application of bioethical principles, and the integration of GINA regulations for advanced nursing practice assessments.

NUR3306: Integration of Genetics and Genomics into Ethical Nursing Practice

Navigating the intersection of modern science and human values is a core competency for today’s nursing professionals. This course focuses on the moral landscape of genomic medicine, ensuring that as we unlock the secrets of the human code, we remain steadfast in our commitment to patient advocacy, privacy, and social justice.

Assessment 1: Ethical Inquiry into Direct-to-Consumer (DTC) Genetic Testing

Overview

This assignment explores the ethical complexities surrounding Direct-to-Consumer (DTC) genetic tests. As these kits become more accessible, nurses are increasingly tasked with helping patients interpret results that carry significant psychological and social weight. You will analyze a specific case through the lens of nursing ethics and the ANA Code of Ethics.

Instructions and Guidelines

1. Case Study Selection

   • Choose one scenario involving DTC testing (e.g., discovery of non-paternity, unexpected predisposition to a late-onset neurodegenerative disorder like Alzheimer’s, or secondary findings related to cancer risk).

     Stuck on Your Assignment?

     Cola Papers Experts Are Ready Right Now

     Join thousands of students who submit confidently. Human-written, plagiarism-checked, and formatted to your institution's exact standards.

     Order My Custom Paper Use code BISHOPS for 25% off

   • Describe the patient’s initial motivation for testing and the subsequent clinical or emotional dilemma.

2. Ethical Framework Application

   • Analyze the case using the four principles of bioethics: Autonomy, Beneficence, Non-maleficence, and Justice.

   • Evaluate the tension between a patient’s “right to know” and the “right not to know,” particularly regarding family members who share the same genetic material.

3. Privacy and Advocacy Analysis

   • Discuss the implications of data privacy in the digital age. Who owns the genetic data once it is uploaded to a commercial server?

   • Identify the nurse’s role in advocating for the patient during the informed consent process before and after receiving results.

4. Policy and Legal Integration

   • Incorporate the Genetic Information Nondiscrimination Act (GINA) into your discussion. Explain its protections and its limitations (e.g., life insurance and long-term care insurance exclusions).

Discussion Board Component

• Initial Post (300-400 words): Present your chosen case and identify the primary ethical conflict. Propose one strategy a nurse could use to support the patient’s autonomy.

• Peer Responses (2): Engage with two classmates. Contrast their ethical approach with your own and suggest one potential unintended consequence of their proposed strategy.

Grading Rubric Details

References

• Badzek, L., Henaghan, M., Turner, M. and Monsen, R. (2020). ‘Ethical, Legal, and Social Issues in the Era of Genomic Medicine’, Journal of Nursing Scholarship, 52(6), pp. 614-622. https://doi.org/10.1111/jnu.12596

• Kirk, M. and Morgan, R. (2023). ‘The Nurse’s Role in Genomic Informed Consent’, Nursing Ethics, 30(2), pp. 145-159. https://doi.org/10.1177/09697330221134567

• Lewis, A. C. and Green, R. C. (2024). ‘Direct-to-Consumer Genetic Testing: Ethical and Clinical Implications’, Annual Review of Genomics and Human Genetics, 25, pp. 201-220. https://doi.org/10.1146/annurev-genom-121223-110000

• National Human Genome Research Institute (2025). Ethical, Legal and Social Implications (ELSI) Program. Available at: https://www.genome.gov/elsi